Cor D. de Kroon
Papers
1
Total Citations
26
H-Index
1
About
Cor D. de Kroon is a leading figure in gynecologic oncology, whose research has fundamentally reshaped surgical standards for early-stage cervical cancer. His primary contributions lie in the design and execution of large-scale, practice-changing clinical trials that prioritize de-escalation of treatment to reduce patient morbidity without compromising oncologic safety. Dr. de Kroon is best known for his pivotal role in the international, phase III SHAPE trial, a landmark study that compared radical hysterectomy with the less extensive simple hysterectomy for low-risk early-stage cervical cancer. This work, published in 2023, has already garnered significant attention and is redefining surgical guidelines globally by demonstrating that less radical surgery can be both safe and associated with substantially less long-term side effects. Through his leadership within the Gynecologic Cancer Intergroup (GCIG), he has championed collaborative, high-impact research that directly translates to improved quality of life for patients. With a career dedicated to evidence-based surgical innovation, Dr. de Kroon’s legacy is one of meticulous clinical investigation, proving that sometimes, less is truly more in the fight against cancer.
Research Focus
Key Achievements
Top Papers
- 1